Next Article in Journal
Transport of Twelve Coumarins from Angelicae Pubescentis Radix across a MDCK-pHaMDR Cell Monolayer—An in Vitro Model for Blood-Brain Barrier Permeability
Previous Article in Journal
Iridium-Catalysed ortho-Directed Deuterium Labelling of Aromatic Esters—An Experimental and Theoretical Study on Directing Group Chemoselectivity
Previous Article in Special Issue
Prevention of Protein Glycation by Natural Compounds
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Redox-Active Profile Characterization of Remirea maritima Extracts and Its Cytotoxic Effect in Mouse Fibroblasts (L929) and Melanoma (B16F10) Cells

by
Grace Anne A. Dória
1,
Anderson R. Santos
1,
Leonardo S. Bittencourt
2,
Rafael C. Bortolin
2,
Paula P. Menezes
1,
Bruno S. Vasconcelos
1,
Rebeca O. Souza
3,
Maria José V. Fonseca
3,
Alan Diego C. Santos
4,
Shanmugam Saravanan
1,
Francilene A. Silva
1,
Daniel P. Gelain
2,
José Cláudio F. Moreira
2,
Ana Paula N. Prata
5,
Lucindo J. Quintans-Júnior
4 and
Adriano A. S. Araújo
1,*
1
Departament of Pharmacy, Federal University of Sergipe, Av. Marechal Rondon, Jardim Rosa Elze, 49100-000 São Cristóvão, Sergipe, Brazil
2
Departament of Biochemistry, Federal University of Rio Grande do Sul, 90040-060 Porto Alegre, Rio Grande do Sul, Brazil
3
Departament of Pharmacy, University of São Paulo, 14040-900 Ribeirão Preto, São Paulo, Brazil
4
Departament of Physiology and Chemistry, Federal University of Sergipe, 49100-000 São Cristóvão, Sergipe, Brazil
5
Departament of Biology, Federal University of Sergipe, 49100-000 São Cristóvão, Sergipe, Brazil
*
Author to whom correspondence should be addressed.
Molecules 2015, 20(7), 11699-11718; https://doi.org/10.3390/molecules200711699
Submission received: 8 December 2014 / Revised: 6 May 2015 / Accepted: 12 May 2015 / Published: 25 June 2015
(This article belongs to the Special Issue Natural Antioxidants and Ageing)

Abstract

:
Remirea maritima is a tropical plant with a reticulated root system belonging to the family Cyperaceae, also known to have biologically active secondary metabolites. However, very few data on R. maritima’s biological actions are available and there are no reports regarding the redox-active profile of this plant. In this study, we examined the total phenolic content of Remirea maritima hydroalcoholic (RMHA) extracts, redox properties against different reactive species generated in vitro and their cytotoxic effect against fibroblasts (L929) and melanoma (B16F10) cells. Total reactive antioxidant potential index (TRAP) and total antioxidant reactivity (TAR) results revealed that RMHA at all concentrations tested showed significant antioxidant capacity. RMHA was also effective against hydroxyl radical formation, reduction of Fe3+ to Fe2+ and in scavenging nitric oxide (NO) radicals. In vitro, the level of lipid peroxidation was reduced by RMHA extract and the data showed significant oxidative damage protection. The RMHA cytotoxicity was evaluated by a neutral red assay in fibroblast (L929) and melanome (B16F10) cells. The obtained results showed that the RMHA (40 and 80 µg/mL, respectively) reduced 70% of the viable cells. In conclusion, this study represents the first report regarding the antioxidant and anti-proliferative potential of R. maritima against B16F10 melanoma cells.

1. Introduction

The pathogenesis of numerous chronic diseases has been related with unbalanced levels of free radicals in systemic tissues [1]. Epidemiological surveys indicate that the diet plays an important role in preventing chronic diseases due to the antioxidants it supplies [2,3,4].
Plant-based foods contain significant amounts of phytochemicals which possess numerous health benefits [5]. These phytochemicals are mostly phenols, which can be divided into at least 10 types depending on their basic structure. The flavonoids represent the most important type of polyphenolic compound [6]. Several studies have previously reported that many of these phytochemicals have antioxidant activity, and anticarcinogenic and antimutagenic effects by inhibiting cell proliferation [7,8,9,10]. Furthermore, antioxidants are the main compounds considered to exert anti-inflammatory, anti-aging and health-promoting effects in the human body [11].
Remirea maritima Aubl. is a tropical plant belonging to the family Cyperaceae with a reticulated root system that develops rhizomes below the sand. This family is known to contain biologically active secondary metabolites such as xanthones, chalcones, coumarins, flavonoids, triterpenes, benzofurans, etc. [12]. R. maritima is popularly employed in medicinal preparations for the treatment of diarrhea, kidney disease, fever, pain, and inflammatory processes [13,14]. At the moment, there are few reported studies about the chemistry and pharmacology of R. maritima plants. Recently, the aqueous extract was evaluated for chemical composition, thiobarbituric acid reactive species (TBARS) and nitric oxide (NO) assays, anti-inflammatory and antinoceptive properties. The phytochemical profile of the aqueous extract showed three flavone glycosides (vitexin, isovitexin and luteolin) as components and it presented an effective anti-inflammatory activity and reduced NO and lipid peroxidation [15]. The phytochemical characterization, and antitumor effects of RMHA were studied by our group and we have reported vitexin, isovitexin, luteolin and cafeoil as components and it also showed antitumor activity [16]. The work heported herein now provides the first data regarding the complete in vitro redox-active properties and the cytotoxicity of R. maritima hydroalcoholic extracts.

2. Results

2.1. Determination of Total Phenolic Content (TPC)

The total phenolic content in RMHA was analyzed by the Folin-Ciocalteau method and estimated by comparison with a standard phenolic compound (gallic acid). Total phenolic content of the extract was 0.58 mg gallic acid equivalents/g of RMHA extract.

2.2. Total Reactive Antioxidant Potential (TRAP) and Total Antioxidant Reactivity (TAR)

The general antioxidant capacity of RMHA extract was evaluated by the TRAP and TAR assays. In the TRAP assay, RMHA concentrations ranging from 0.001 to 100 µg/mL showed a significant dose-dependent antioxidant effect (Figure 1A). At the concentrations of 10 and 100 µg/mL, RMHA extract revealed the best results, similar to those of Trolox® (75 µg/mL) used as a reference antioxidant. RMHA concentration ranges 0.1 to 100 µg/mL also showed a significant antioxidant capacity in the TAR assay (Figure 1B) and a concentration of 100 µg/mL RMHA extract showed better results than the control and Trolox® groups.
Figure 1. (A) Total reactive antioxidant potential (TRAP) assay; (B) Calculated total antioxidant reactivity (TAR) values. Trolox® (75 µg/mL) was used as standard antioxidant. Bars represent mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Figure 1. (A) Total reactive antioxidant potential (TRAP) assay; (B) Calculated total antioxidant reactivity (TAR) values. Trolox® (75 µg/mL) was used as standard antioxidant. Bars represent mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Molecules 20 11699 g001

2.3. Hydroxyl Radical-Scavenging Activity

Degradation of 2-deoxyribose (2-DR) by hydroxyl radicals generated in vitro by a Fenton reaction was used to evaluate the hydroxyl radical scavenging capacity of RMHA extract. Concentrations of 0.1–100 µg/mL of RMHA extract were effective in scavenging the hydroxyl radicals (Figure 2A), showing similar results to Trolox® (75 µg/mL). RMHA extract at 100 µg/mL was better in reducing hydroxyl radicals than Trolox® (75 µg/mL). We also calculated the IC50 of RMHA hydroxyl scavenging activity, which gave a value of 13.1 µg/mL (Figure 2B).
Figure 2. (A) Hydroxyl radical-scavenging activity quantified using the oxidative in vitro degradation of 2-deoxyribose; (B) Log IC50 of RMHA hydroxyl scavenging activity. TROLOX® (75 µg/mL) was used as standard antioxidant. Bars represent mean ± SEM. *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Figure 2. (A) Hydroxyl radical-scavenging activity quantified using the oxidative in vitro degradation of 2-deoxyribose; (B) Log IC50 of RMHA hydroxyl scavenging activity. TROLOX® (75 µg/mL) was used as standard antioxidant. Bars represent mean ± SEM. *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Molecules 20 11699 g002

2.4. Ferric Reducing Antioxidant Power (FRAP) and Fe2+ Chelation Assay

To evaluate whether RMHA was able to reduce Fe3+ to Fe2+, we performed the FRAP assay. All tested concentrations are able to reduce iron, however at a concentration of 10 µg/mL RMHA showed similar results to Trolox® (75 µg/mL) and at a concentration of 100 µg/mL RMHA was more efficient than the standard antioxidant in reducing the iron (Figure 3).
Figure 3. Ferric Reducing Antioxidant Power (FRAP). Trolox® (75 µg/mL) was used as standard antioxidant. ### less efficiency than Trolox® (p < 0.0001); NS Non-significant compared to Trolox®; *** higher efficiency than Trolox® (p < 0.0001) (1-way ANOVA followed by Tukey’s multiple comparison post hoc test); bars represent mean ± SEM.
Figure 3. Ferric Reducing Antioxidant Power (FRAP). Trolox® (75 µg/mL) was used as standard antioxidant. ### less efficiency than Trolox® (p < 0.0001); NS Non-significant compared to Trolox®; *** higher efficiency than Trolox® (p < 0.0001) (1-way ANOVA followed by Tukey’s multiple comparison post hoc test); bars represent mean ± SEM.
Molecules 20 11699 g003
Ferrous ion-chelating activity is an important indicator of oxidative stress involving Fe2+ ion. Ferrozine forms red complexes with Fe2+ quantifiable by spectrophotometry. In the presence of chelating agents the complex formation is disrupted or prevented, resulting in a decrease in the red color of the complex. Measurement of the color reduction allows estimation of the metal chelating activity of the analysed extract. All RMHA extracts were efficient in chelating ferrous ion (Figure 4A), thus preventing the aforementioned Fenton reaction and at low IC50 (2.4 µg/mL) (Figure 4B).
Figure 4. (A) The ability of RMHA extracts in prevent the Fe2+-ferrozine complex formation, thus decreasing the red color compared to control; (B) Log IC50 graph. EDTA was used as standard chelating agent. Bars represent average ± SEM of three independent experiments. *** p < 0.001 (1-way ANOVA followed by Tukey’s post-hoc test).
Figure 4. (A) The ability of RMHA extracts in prevent the Fe2+-ferrozine complex formation, thus decreasing the red color compared to control; (B) Log IC50 graph. EDTA was used as standard chelating agent. Bars represent average ± SEM of three independent experiments. *** p < 0.001 (1-way ANOVA followed by Tukey’s post-hoc test).
Molecules 20 11699 g004

2.5. Nitric Oxide (NO·) Scavenging Activity

The ability of RMHA to scavenge NO was measured by quantifying the production of nitrite derived from sodium nitroprusside (SNP) by the Griess reaction.
All tested concentrations of RMHA (0.1–100 µg/mL) showed NO radical scavenging capacity (Figure 5A). RMHA was more active than Trolox®. The IC50 value of the RMHA scavenging effect upon SNP-induced NO production was also calculated, giving a result of 4.04 µg/mL (Figure 5B).
Figure 5. Nitric oxide (NO) scavenging assay (A) NO was generated from spontaneous decomposition of sodium nitroprusside (SNP) in the presence O2, producing NO2 ions which were measured by the Griess reaction. Trolox® (75 µg/mL) was used as standard antioxidant; (B) Log IC50 of RMHA NO scavenging activity. Bars represent mean ± SEM. *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Figure 5. Nitric oxide (NO) scavenging assay (A) NO was generated from spontaneous decomposition of sodium nitroprusside (SNP) in the presence O2, producing NO2 ions which were measured by the Griess reaction. Trolox® (75 µg/mL) was used as standard antioxidant; (B) Log IC50 of RMHA NO scavenging activity. Bars represent mean ± SEM. *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Molecules 20 11699 g005

2.6. Thiobarbituric Acid Reactive Species (TBARS)

The capacity of RMHA to protect from oxidative damage by lipid peroxidation was measured by quantification of thiobarbituric acid-reactive substances (TBARS) generated by AAPH in a lipid-rich incubation medium. The effect of different concentrations of RMHA on lipid peroxidation is shown in Figure 6A. At concentrations of 1–100 µg/mL, RMHA reduced the AAPH-induced lipid peroxidation when compared with standards. At concentrations of 10–100 µg/mL, RMHA shows better protection against lipid peroxidation than Trolox®. Figure 6B shows the IC50 value describing the ability of RMHA to prevent lipid peroxidation, which was 4.04 µg/mL.
Figure 6. TBARS assay in vitro. (A) Effect of different concentrations of RMHA on lipid peroxidation; (B) Log IC50 of RMHA lipid peroxidation activity. Trolox® (75 µg/mL) was used as standard antioxidant. Bars represent mean ± SEM. ** p < 0.01, *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Figure 6. TBARS assay in vitro. (A) Effect of different concentrations of RMHA on lipid peroxidation; (B) Log IC50 of RMHA lipid peroxidation activity. Trolox® (75 µg/mL) was used as standard antioxidant. Bars represent mean ± SEM. ** p < 0.01, *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Molecules 20 11699 g006

2.7. Cytotoxicity Assay

Cytotoxicity evaluation was conducted in two strains of cells, normal L929 fibroblast cells (Figure 7A) and melanoma B16F10 tumor cells (Figure 7B).
Figure 7. Effect of RMHA on cell viability at different concentrations assessed by a neutral red assay. (A) L929—fibroblast cells and (B) B16F10—melanoma cells. Control group received distilled water (1:1). n = 4, ** p < 0.01, *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Figure 7. Effect of RMHA on cell viability at different concentrations assessed by a neutral red assay. (A) L929—fibroblast cells and (B) B16F10—melanoma cells. Control group received distilled water (1:1). n = 4, ** p < 0.01, *** p < 0.001 (1-way ANOVA followed by Tukey’s multiple comparison post hoc test).
Molecules 20 11699 g007
RMHA showed cytotoxic activity with an IC50 value of 70.96 µg/mL (65.59–77.96) in L929 cells and an IC50 value of 108.30 µg/mL (101.90–115.00) in B16F10 cells. At 80 µg/mL RMHA exhibited a significant reduction of viable melanoma cells, while a significant decrease of normal cells only started to appear at a 20 µg/mL concentration of RMHA.

3. Discussion

Numerous reports suggest that reactive oxygen species (ROS) and reactive nitrogen species (RNS) are involved in the pathogenesis of several diseases such as cancer, inflammatory diseases, neurodegenerative disorders, hypertension, diabetes and cardiovascular disorders [17,18,19,20,21].
ROS/RNS are free radicals, which are atoms or groups with highly reactive unpaired electrons [22]. ROS represent a class of the most important free radicals produced in living systems. Oxygen is essential for the survival of aerobic beings, however, the process of reduction of oxygen and water in generating ATP can produce ROS such as superoxide (·O2) as intermediates and non-free radicals, such as hydrogen peroxide (H2O2), which causes potential damage to cells [19].
On the other hand, ROS/RNS, under normal physiological conditions, participate as regulatory molecules, intracellular messengers, tissue protection against further insults, controlling cell proliferation by inducing apoptosis and defending against cancer [23,24,25]. Thus, ROS, as byproducts of oxygen metabolism, are constantly produced in the human body and removed by antioxidant defenses by different pathways, antioxidant compounds, antioxidant enzymes, proteins and exogenous components as carotenoids, flavonoids, and other phenolic compounds, including vitamin E, vitamin C and coumarin derivatives [26,27,28]. Briefly, oxidative stress can play an important role in the pathogenesis of diseases and that can be counteracted through the natural scavenging system which balances ROS generation and elimination [29].
Antioxidants are compounds that at low concentrations prevent or interfere in the oxidation of oxidisable substrates such as DNA, lipids, and proteins. In biological systems, there are two main classes of the antioxidants systems: the enzymatic and nonenzymatic [30] antioxidant systems.
Several studies have shown that the redox activity from natural antioxidants is related to the total content of phenolic compounds [31,32,33]. Generally these compounds are present at high levels in vegetables and fruits, which thus have the capacity to reduce oxidative stress [6,34,35].
The TPC of RMHA was evaluated using the Folin–Ciocalteu reagent. The plant extract showed a higher level of phenolic compounds (582.5 mg gallic acid/g RMHA extract) compared to the TPC of several other well known plants, such as Acacia podallyriifolia (206.4–338.5 mg gallic acid/g) [36], Terminalia brasiliensis, Terminalia fagifolia, Copernicia cerifera, Cenostigma macrophyllum, Qualea grandiflora (250.0–763.6 mg gallic acid/g) [37], Limnocharis flava, Momordica charanti, Eugenia siamensis, Piper betel, Acacia catechu (5.4–180.5 mg gallic acid/g) [38] and Morinda citrifolia (196.8 mg gallic acid/g) [39]. This high TPC is what led us to investigate the redox-active profile of RMHA extracts since phenolic compounds are described to have antioxidant properties [40,41]. The redox properties of RMHA were evaluated using different approaches to understand the possible effects in different reactive species-generating sources, such as superoxide radical (O2.), hydroxyl (.OH), peroxyl, nitric oxide (.NO) and redox active metals.
TRAP/TAR assays showed the general antioxidant ability of RMHA. TRAP and TAR are different methods employed to estimate the general antioxidant potential and capacity of samples in vitro. In Figure 1A, the bars represent the area under the curve of a kinetic measurement of AAPH-induced luminescence during 120 min (TRAP measurement); in the TAR assay, the immediate effect of the addition of an antioxidant compound in the free radical-induced chemiluminescence is measured [42]. The RMHA extracts was able to maintain the AAPH-induced free radical production inhibited during 120 min (TRAP assay) at all tested concentrations (Figure 1A). Regarding TAR measurements, RMHA showed high efficiency in inhibiting the AAPH-induced free radical production when immediately added to a system at concentrations ranging from 0.1 to 100 µg/mL (Figure 1B). As we can see in Figure 1A, the concentrations of 0.001 and 0.01 µg/mL presented suitable antioxidant kinetic behavior, but low antioxidant quality when the TAR measurements were analyzed (Figure 1B), thus justifying why such concentrations were chosen for the other analyses described in this study.
Peroxyl radicals formed in the TRAP reaction participate in the initiation and propagation steps of lipid peroxidation and can produce cytotoxic and genotoxic products. These toxic products promote cell damage involved in the pathogenesis of many diseases [1,43].
Moreover, RMHA was capable of quenching hydroxyl radicals. The extract was thus highly effective in inhibiting 2-DR hydroxyl-induced damage. Doses of 0.1 to 100 μg/mL showed a significant antioxidant activity, which was similar to that of Trolox® (Figure 2). The Fenton reaction is an important source of hydroxyl radicals. This reaction is due to the combination of hydrogen peroxide and free iron inside the cell. In this study, we demonstrated that the RMHA extracts are able to quench hydroxyl radicals, and thinking about Fenton chemistry, one last question needed to be answered. Are the RMHA extracts capable of reducing and chelating iron thus minimizing the Fenton reaction? At all tested concentrations, RMHA proved to be efficient in reducing free iron, but only 10 and 100 µg/mL showed similar or better performance, respectively, to Trolox® (Figure 3). The ferrous ion (Fe2+) is required for oxygen and electron transport and participates in the activities of many enzymes and the physiological concentrations in the human body are capable of participating in Fenton reactions, thus generating hydroxyl radicals [22]. The RMHA extracts were able to chelate Fe2+ at all tested concentrations, thus preventing the hydroxyl radical generation (Figure 4). It is important to mention that the aforementioned redox active metals are involved in neurodegenerative diseases, such as Alzheimer’s, where high iron concentrations were found in neural plaques, increasing the oxidative damage, whereas the amyloid beta deposition enhances the H2O2 generation and consequently the generation of hydroxyl radicals by Fenton chemistry. Based on these results, RMHA could represent a promising alternative to prevent or decrease the oxidative damage caused by the most reactive and harmful radical, the hydroxyl radical.
NO· is an important mediator of acute and chronic inflammation by stimulation of cyclooxygenase (COX) activity resulting in unbalanced production of pro-inflammatory prostaglandins. The ability of RMHA to scavenge NO· was measured by quantifying the production of nitrite derived from sodium nitroprusside (SNP) by the Griess reaction. The data shows that 0.1 to 100 µg/mL concentrations of RMHA significantly decreased SNP-derived nitrite formation, indicating a potential role as a NO scavenging substance (Figure 5) and, therefore, it might regulate the production of these reactive species in biological systems. Rabelo et al. [15] have evaluated the antinociceptive and anti-inflammatory activity of aqueous extract of Remirea maritima and the results suggested that this extract has an antiinflammatory action probably mediated via inhibition of peripheral mediators (such as the synthesis of prostaglandins, NO, ROS). However, the aqueous extract only reduced NO formation at concentrations of 100 µg/mL to 1 mg/mL [15], while the RMHA showed significantly decreased nitric oxide production at 0.1 to 100 µg/mL and all of them were greater than Trolox® (Figure 5). In neurodegenerative diseases the inflammatory scenario is considered a pivotal feature that contributes significantly to the increase in oxidative stress and hence the progression of the disease. A pro-inflammatory condition could lead to a nitric oxide overload, increasing the oxidative damage due to peroxynitrite formation.
Lipid peroxidation can be defined as a cascade of biochemical events resulting from the action of free radicals on the unsaturated lipids of cell membranes, which leads to alteration of permeability, loss of selectivity for input and/or output of nutrients and toxic substances to the cell, DNA changes, oxidation of LDL and commitment of extracellular matrix components [44]. RMHA at 1 to 100 µg/mL concentration was able to prevent the in vitro lipid peroxidation as evidenced from the TBARS assay (Figure 6A). Rabelo et al. [15] also tested the lipid peroxidation ability of aqueous extract of Remirea maritima and this extract significantly inhibited free radicals induced by TBARS at concentrations of 100 µg/mL to 1 mg/mL [15]. According to the medicinal plant literature, natural products which present a reduction in lipid peroxidation from 10 µg/mL are considered to have high antioxidant potential [36,37]. RMHA showed IC50 values of 7.5 µg/mL (Figure 6B), indicating a strong potential in decreasing lipid peroxidation in vitro.
To summarize, in this study, the RMHA extracts presented more efficient antioxidant activities in TRAP/TAR, FRAP, chelating activity, hydroxyl and nitric oxide scavenging activities compared with plant extracts or isolated compounds assessed by other groups, using the same approach used in the present work to investigate them [15,40,45,46,47,48].
Some studies consider that water/alcohol solvent is better than water solvent for the extraction of phenolic agents [6,49]. Since the antioxidant activity is related to total phenolic content, the RMHA redox properties are probably due to the presence of a high polyphenol content.
Several polyphenol substances found in plant-derived diets have been shown to be able to inhibit proliferation and induce apoptosis in tumor cells [7,8,10]. One of the reasons for carcinogenesis is ROS production. In addition, ROS can specifically trigger certain pathways involved in tumor proliferation, contributing to genomic instability [26].
The global incidence of skin cancer around the world is high and 132,000 new melanoma skin cancers occur globally each year [50], thus, the RMHA was evaluated for cytotoxicity in normal cells and for the ability to inhibit the proliferation of melanoma cell lines. The selective index (SI) is often used to evaluate the differential toxicity of a compound, which is determined as a ratio between IC50 values of normal and cancerous cells. An SI value lower or equal of 2 suggests the general toxicity of pure compound in cells [51]. The SI for RMHA between fibroblast and melanoma cells was 0.65, therefore, the results showed that, although, it presented a significantly reduction of viable cells of B1610 melanoma cells at concentrations of 80 to 320 µg/mL, RMHA was not selective for melanoma skin cancer cells when compared with normal fibroblast cells (Figure 7).
It is important to mention that the IC50 value (70.96 µg/mL) of RMHA in reducing the fibroblast cell viability was 5.41, 29.56, 17.74 and 9.46 times higher than IC50 value shown in the in vitro antioxidants tests (EROs, IC50 13.1 µg/mL; ferrous ion-chelating, IC50 2.4 µg/mL; NO scavenging, IC50 4.0 µg/mL and TBARS, IC50 7.5 µg/mL, respectively), which does not preclude its applicability as an antioxidant agent since the therapeutic concentration is lower than the toxic concentration for normal cells.
A previous chemical characterization of RMHA extracts performed by our group identified the the compounds luteolin, vitexin and isovitexin. These compounds are all flavonoids, which were previously reported in the Remirea genus [15], and are known for their antioxidant properties [52,53,54].
Luteolin is a flavone found in a variety of plants, especially vegetables [55,56]. Previous studies showed stronger antioxidant properties and no change potential pro-oxidant activity of luteolin when compared to various common flavonoids, such as quercetin and myricetin, which suggests potential health benefits for humans [57].
Horváthová et al. [58] reported that luteolin has a protective effect against H2O2-induced DNA damage and possesses a protective effect on chromosomal aberrations induced by the cytostatic drug, melphalan, in metastasis of malignant melanoma cells. Besides, luteolin was able to induce cell apoptosis by modulating both the extrinsic pathway and intrinsic pathways, indicating that it triggers caspase-dependant apoptosis [59]. Previous studies have shown that luteolin also reduced the viability of diverse human cancer cell lines. In this study, this flavone was capable to increase the apoptotic of cells through caspase-3- and caspase-7-dependent pathways and was suggested that luteolin is a safe molecule with potential for clinical use in cancer therapy [60].
Isovitexin and vitexin are flavone glycosidea present in some drugs, medicinal plants and nutraceuticals [61]. Isovitexin is already known to exhibit antioxidant potential (inhibition of lipid peroxidation), to reduce the amount of hydrogen peroxide and to inhibit the production and, or release of tumor necrosis factor and prostaglandin E2 (PG2) in inflammatory processes induced by lipopolysaccharide (LPS) in mouse macrophages. These findings suggested that suppression of ROS-mediated COX-2 expression by isovitexin is beneficial in reducing inflammation and carcinogenesis [53].
Vitexin has already shown in different studies anti-oxidant [62], peripheral analgesic and central anti-inflammatory [63,64], anti-viral [65] and anti-convulsant [66] properties. In addition vitexin also showed anti-tumor and anti-metastatic activities and they were associated through a proapoptotic process, which is mediated by a decreased Bcl-2/Bax ratio and activation of caspases [67,68].
Based on this, it would be reasonable to suppose that the broad spectrum of in vitro antioxidant and anti-proliferative effects in melanoma cells presented by RMHA extracts in this study are due to these flavonoids alone or in association. Crude extracts generally consist of a mixture of several different compounds that can acting with antagonistic or synergistic effects. Therefore, it is interesting to suppose that the fractionation of the extract could eliminate toxic compounds which can become fractions with selective antiproliferative effects.

4. Experimental Section

4.1. Chemicals

2,2′-Azobis(2-methylpropionamidine) dihydrochloride (AAPH), 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol), 2-deoxy-D-ribose, glycine, Griess’ reagent, sodium nitroprusside (SNP), 2-thiobarbituric acid (TBA), 4,6-dihydroxypyrimidine-2-thiol, hydrogen peroxide (H2O2), dimethyl sulfoxide (DMSO), 2,4,6-tris(2-piridyl)-s-triazine, ferric chloride, and sodium acetate, were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Materials used in cell culture were acquired from Gibco®/Invitrogen (São Paulo, SP, Brazil) and from the Rio de Janeiro Cell Bank (BCRJ, Rio de Janeiro, Brazil).

4.2. Plant Material and Preparation of R. maritima Extracts

R. maritima (the whole plant) was collected from the beach area of the city of Pirambu (Sergipe, Brazil; 10°55ʹS, 35°6ʹW), on February 2011 and it was identified by Prof. Ana Paula Prata, plant taxonomist, from the Department of Biology/UFS. A voucher specimen (No. ASE 20166) has been deposited in the Herbarium of Department of Biology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil. Permission for plant collection was obtained from the Chico Mendes Institute for Biodiversity Conservation of the Brazilian Ministry of the Environment (permit #25637-1). The whole plant was cleaned, dried and grounded into powder form. The hydroalcoholic extract of R. maritima (RMHA) were prepared by heating 15 g powder/300 mL EtOH/H2O (40% v/v) for 30 min followed by filtration, solvent extraction and lyophilization (RMHA yield: 6.2%). The extract redissolved readily in distilled water which was used as the vehicle.

4.3. Determination of Total Phenolic Content (TPC)

The total phenolic content assay was performed using the Folin–Ciocalteu reagent, with the slight modification of Singleton et al. [69]. RMHA (1 mg) was diluted in water (1 mL). An aliquot (100 µL) of RMHA was then added to deionized water (6 mL) with the Folin–Ciocalteu reagent (500 µL). The mixture was shaken for 1 min. After addition of 15% Na2CO3 solution (2 mL), the mixture was shaken for 0.5 min. The solution was then diluted with deionized water to a final volume of 10 mL. After incubation for 120 min at 23 °C, the total phenolic content was determined at 750 nm using a spectrophotometer. Gallic acid was used as standard, and total phenolic content was expressed as (mg gallic acid equivalents/g of RMHA) estimated from a gallic acid calibration curve. The calibration curve range was 20–350 mg/mL (R2 = 0.999).

4.4. In Vitro Redox-Active Profile

4.4.1. Total Reactive Antioxidant Potential (TRAP) and Total Antioxidant Reactivity (TAR)

Total reactive antioxidant potential (TRAP) is an in vitro non-enzymatic method that is based on the action of antioxidants on the fluorescence decay of luminol-enhanced chemiluminescence generated by the reaction of luminol (o-aminophthaloylhydrazide) with the peroxyl radicals produced by thermal decomposition of the free radical generator AAPH [70,71]. First, the AAPH solution (120 mM final concentration) was prepared by adding the AAPH reagent in 100 mM glycine buffer pH 8.6 (20 mL final volume) followed by addition of luminol (4 µL, 0.001 mM final concentration) in the dark and then we allowed the system to stabilize for 2 h before the first reading [72]. Different concentrations of RMHA were added and the luminescence produced by the free radical reaction was quantified in a liquid scintillator counter (Wallac 1409, Perkin–Elmer, Boston, MA, USA) for 2 h. The system was considered the chemoluminescence emitted by AAPH thermolisys alone. The data were transformed in area under curve (AUC) calculated by software (GraphPad software® San Diego, CA, USA; version 5.0) as previously described [73].
The Total Antioxidant Reactivity (TAR) readings were obtained in the same experiment. These results were calculated as the ratio of light intensity in the absence of samples (I0)/light intensity after RMHA addition [74].

4.4.2. Hydroxyl Radical-Scavenging Activity

This assay measures the ability of antioxidants to scavenge the hydroxyl radicals generated by the reaction between Fe2+ and H2O2 (Fenton reaction). The antioxidant capacity is indirectly determined by measuring (in the presence or absence of extracts) of the amount of malondialdehyde (MDA) generated by reaction between 2-deoxy-d-ribose and hydroxyl radical. The amount of MDA was determined by the absorbance of the chromophore generated in the reaction between MDA and thiobarbituric acid (TBA) measured at 532 nm [71,75].
The reactions were started by the addition of Fe2+ (FeSO4 6 µM final concentration, 100 µL) to solutions containing 50 mM 2-deoxyribose (100 µL, 5 mM final concentration), 1 mM H2O2 (100 µL, 100 µM final concentration) and 20 mM of phosphate buffer (700 µL, pH 7.2).
To measure RMHA antioxidant activity against hydroxyl radicals, different concentrations (0.1 to 100 µg/µL) of RMHA were added to the system before Fe2+ addition. Reactions were allowed to proceed for 15 min at room temperature and then stopped by the addition of 4% phosphoric acid (v/v) followed by 1% TBA addition (w/v, in 50 mM NaOH, 500 µL). Solutions were boiled for 15 min at 95 °C, and then cooled to room temperature. After cooling, the absorbance was measured at 532 nm and results were expressed as percentage of MDA formed related to the reaction system.

4.4.3. Ferric Reducing Antioxidant Power (FRAP)

This assay is used to determine the ability of iron reduction by antioxidants. Briefly, in a dark environment, we added each RMHA extract at the tested concentration (90 µL) to a screw tube followed by addition of distilled water (270 µL) and FRAP reagent (2.7 mL, 2.5 mL of 10 mM TPTZ, 2.5 mL of 20 mM Ferric Chloride and 25 mL of 0.3 M Acetate Buffer pH 3.6). After the mixture was homogenated and incubated in 37 °C for 30 min and readings were performed at 595 nm. A standard curve from a 5 mM ferrous sulphate (Fe2+ source) standard were performed to calculate the amount of Fe2+ produced during the reduction of Fe3+ by RMHA extracts.

4.4.4. Fe2+ Chelation Assay

The ferrous ion-chelating activity of RMHA was estimated as previously described by Cheng et al. [76]. Each RMHA concentration was incubated with 2 mM FeCl2 (50 μL) for 10 min. The reaction was initiated by adding 5 mM ferrozine (200 μL) followed by incubation for 5 min at room temperature. The ferrozine reacts with free iron yielding a red cromophore which absorbance is measured at 562 nm. EDTA (100 μg/mL), a standard chelating agent, served as the positive control. The Fe2+ chelating activity was calculated using the equation below:
Chelating activity (%) = (1 − Absorbance of sample/Absorbance of control) × 100

4.4.5. Nitric Oxide (NO.) Scavenging Activity

Nitric oxide scavenging activity of RMHA extracts was determined from the decomposition of sodium nitroprusside in 20 mM phosphate buffer (pH 7.4) generating NO. Nitrite ions produced by interaction between the NO generated with oxygen were measured by the Griess reaction [77]. The reaction mixture is composed by 10 mM sodium nitroprusside (SNP) in phosphate buffer (pH 7.4) and RMHA at different concentrations totaling 1 mL final volume. This mixture were incubated at 37 °C for 1 h and after this, an aliquot of 0.5 mL was taken and homogenized with 0.5 mL Griess reagent. The absorbance of chromophore was measured at 540 nm. Results were expressed as percentage of nitrite formed compared to SNP alone representing 100% nitrite production.

4.4.6. Thiobarbituric Acid Reactive Species (TBARS)

The thiobarbituric acid-reactive substances (TBARS) assay was employed to quantify lipid peroxidation [78]. The TBARS method is used to measure the antioxidant capacity of RMHA extract using egg yolk homogenate as lipid rich substrate [79]. First, egg yolk was homogenized (1% w/v) in 20 mM phosphate buffer (pH 7.4), sonicated at power 4 and 1 mL of emulsion was mixed with 0.1 mL of RMHA at different concentrations. Then, AAPH solution (0.1 mL, 0.12 M) was added as a peroxyl radical generating source to induce the lipid peroxidation. Incubation medium alone (egg yolk + PB 20 mM) without AAPH was used as control. Reactions were carried out at 37 °C. Samples were taken after 30 min and an aliquot (0.5 mL) were centrifuged with trichloroacetic acid (0.5 mL, final concentration 10%) at 10,000 g for 10 min. A portion of the supernatant (0.5 mL) was mixed with TBA (0.5 mL, 0.67%), heated at 95 °C for 30 min and cooled to room temperature. The sample’s absorbance was measured by using a spectrophotometer at 532 nm and the results were expressed as percentage of MDA formed compared to induced control (AAPH alone).

4.5. Cells Line and Culture Conditions

The cytotoxicity assay of RMHA was performed using L929 (mouse fibroblasts) and B16F10 (melanoma) cell lines, all obtained from the Cell Bank of Rio de Janeiro, Brazil. Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM), supplemented with 10% fetal bovine serum, 100 μg/mL streptomycin and 100 U/mL penicillin. The medium was replaced every two days and the cells were maintained at 37 °C in a 5% CO2 atmosphere.

In Vitro Cytotoxicity Assay

Cytotoxic activity was performed by the neutral red assay. This method is based on the uptake of dye by the lysosomes of viable cells [80,81]. Cells were seeded at a density of 105 cells/well into 96-well plates and incubated for 24 h at 37 °C and 5% CO2. Then, 20 µL of RMHA, at different concentrations (10–360 μg·mL−1) in water was added to the culture plates for 24 h. After treatment, cells were rinsed once with saline. Cells were then incubated for 3 h with neutral red solution (50 µg/mL in the well). Thereafter the medium was removed, the cells were washed quickly with an aqueous solution of 1% of formaldehyde and 1% of CaCl2, and then 200 µL of a solution of 1% acetic acid and 50% ethanol was added to each well to extract the dye. After agitation the plate was transferred to a microplate reader equipped with a 540 nm filter (Cary 50 Bio UV Visible, spectophotometer, Varian, Inc., Melbourne, Australia) to measure the absorbance. The cellular viability is express as the percentage of viable cells compared to the control group. For each assay, RMHA (6.25 mg·mL−1) was dissolved in distilled water and serial dilutions were obtained from this stock solution.

4.6. Statistical Analysis

The in vitro antioxidant assays were carried out with RMHA extract n = 3 (i.e., 3 vials per group). The differences among data were evaluated by one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test. The results were expressed as mean ± standard error of the mean (SEM) of three independent experiments. The cell culture experiments were performed with n = 4 and the results were expressed as mean ± standard error of the mean (SEM) of four independent experiments. The IC50 was calculated by non-linear regression fit analisys. In all cases differences were considered significant if p < 0.05. Data analyses were performed using the (GraphPad software® San Diego, CA, USA; version 5.0).

5. Conclusions

In conclusion, the hydroalcoholic extract of R. maritima contains a high amount of total phenols and previous studies showed the presence of some flavonoids, which have potential anti-tumor, anti-metastatic, anti-inflammatory and anti-oxidant activities. Although these constituents are known to present several beneficial activities, until at the moment no study has demonstrated synergism of these compounds in their in vitro antioxidant and anti-proliferative activity on skin cells. The strong and efficient antioxidant properties of RMHA by different mechanisms are presented in this study for the first time. Some concentrations of this extract exhibited greater antioxidant capacity than the standard commercial antioxidant product Trolox®. Further, the promising results obtained in this study also suggest that in vivo approaches are needed to better evaluate the RMHA potential profile as a herbal medicine to prevent various diseases related to unbalanced production of oxygen and nitrogen reactive species. Additionally, it could serve as a chemopreventive agent or as adjuvant in chemotherapy against melanoma cells, however, further evaluations should be performed to confirm the anti- carcinogenic activity of this plant extract.

Acknowledgments

The authors are grateful to CAPES, CNPq, FINEP and FAPITEC/SE for financial support and fellowships. This work was performed according to the special authorization for access to genetic resources in Brazil #010240/2013-6, issued by CNPq/MCTI.

Author Contributions

GAAD and ROS were responsible for determining the cytotoxicity; ARS, PPM and BSV were responsible for collecting and cleaning the Remirea maritima plant and preparing the extract; LSB and RCB were responsible to determining the redox in vitro activities; SS corrected the English language; ADCS and FAS were responsible for performing the determination of total phenolic content; APNP, plant taxonomist, identified the plant; JCFM participated in the experimental design and coordination and helped to draft the manuscript; MVF, DPG and LJQ helped prepare the manuscript, participated in the design of the study of all experimental work and provided the discussion; AASA as project leader, contributed to editing of the manuscript and financial support.

Conflicts of Interest

The authors have declared that there is no conflict of interest.

References

  1. Wu, L.; Hsu, H.; Chen, Y.; Chiu, C.; Lin, Y.; Ho, J.A. Antioxidant and antiproliferative activities of red pitaya. Food Chem. 2006, 95, 319–327. [Google Scholar] [CrossRef]
  2. Bauman, A.E. Updating the evidence that physical activity is good for health: An epidemiological review 2000–2003. J. Sci. Med. Sport 2004, 7, 6–19. [Google Scholar] [CrossRef]
  3. Rosillo, M.A.; Sánchez-Hidalgo, M.; Cárdeno, A.; Aparicio-Soto, M.; Sánchez-Fidalgo, S.; Villegas, I.; Lastra, C.A. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol. Res. 2012, 66, 235–242. [Google Scholar] [CrossRef] [PubMed]
  4. Chen, A.Y.; Chen, Y.C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Review Article. Food Chem. 2013, 138, 2099–2107. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 2003, 78, 517–520. [Google Scholar]
  6. Miguel, M.G.; Nunes, S.; Dandlen, S.A.; Cavaco, A.M.; Antunes, M.D. Phenols and antioxidant activity of hydro-alcoholic extracts of propolis from Algarve, South of Portugal. Food Chem. Toxicol. 2010, 48, 3418–3423. [Google Scholar] [CrossRef] [PubMed]
  7. Androutsopoulos, V.P.; Ruparelia, K.; Arroo, R.R.J.; Tsatsakis, A.M.; Spandidos, D.A. CYP1mediatedantiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Toxicology 2009, 264, 162–170. [Google Scholar] [CrossRef] [PubMed]
  8. Gao, D.; Jin, F.; Liu, H.; Wang, Y.; Jiang, Y. Metabonomic study on the antitumor effect of flavonoid derivative 3d in HepG2 cells and its action mechanism. Talanta 2014, 118, 382–388. [Google Scholar] [CrossRef] [PubMed]
  9. Kim, H.; Moon, J.Y.; Kim, H.; Lee, D.S.; Cho, M.; Choi, H.K.; Kim, Y.S.; Mosaddik, A.; Cho, S.K. Antioxidant and antiproliferative activities of mango (Mangifera indica L.) flesh and peel. Food Chem. 2010, 121, 429–436. [Google Scholar] [CrossRef]
  10. Malta, L.G.; Tessaro, E.P.; Eberlin, M.; Pastore, G.M.; Liu, R.H. Assessment of antioxidant and antiproliferative activities and the identification of phenolic compounds of exotic Brazilian fruits. Food Res. Int. 2013, 53, 417–425. [Google Scholar] [CrossRef]
  11. Becker, K.; Schroecksnadel, S.; Gostner, J.; Zaknun, C.; Schennach, H.; Überall, F.; Fuchs, D. Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds. Phytomedicine 2014, 21, 164–171. [Google Scholar] [CrossRef] [PubMed]
  12. Lasekan, O. Volatile constituents of roasted tigernut oil (Cyperus esculentus L.). J. Sci. Food Agric. 2013, 93, 1055–1061. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Allan, R.D.; Wells, R.J.; Macleod, I.K. Flavanone quinones from Cyperus species. Tetrahedron Lett. 1973, 1, 7–8. [Google Scholar] [CrossRef]
  14. Siani, A.C.; Silva, A.M.P.; Nakamura, M.J.; Carvalho, M.V.; Henriques, M.G.O.; Ramos, M.F.S.; Kaiser, C.R. Chemical Composition and Anti-Inflammatory Activity of the Hydrodistillate from Mariscus pedunculatu. J. Braz. Chem. Soc. 2001, 12, 354–359. [Google Scholar] [CrossRef]
  15. Rabelo, A.S.; Oliveira, I.D.; Guimarães, A.G.; Quintans, J.S.S.; Prata, A.P.N.; Gelain, D.P.; Venceslau, E.M.; Santos, J.P.A.; Quintans-Júnior, L.J.; Bonjardim, L.R.; et al. Antinociceptive, anti-inflammatory and antioxidant activities of aqueous extract from Remirea maritima (Cyperaceae). J. Ethnopharmacol. 2013, 145, 11–17. [Google Scholar] [CrossRef] [PubMed]
  16. Dória, G.A.A.; Menezes, P.P.; Lima, B.S.; Vasconcelos, B.S.; Silva, F.A.; Henriques, R.M.; Melo, M.G.D.; Alves, A.V.F.; Moraes, M.O.; Pessoa, C.O.; et al. In vivo antitumor effect, induction of apoptosis and safety of Remirea maritima Abul. (Cyperaceae) extracts. Phytomedicine 2015, in press. [Google Scholar]
  17. Ceriello, A.; Motz, E. Is oxidative stress the pathogenic mechanism under-lying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 816–823. [Google Scholar] [CrossRef] [PubMed]
  18. Huynh, K.; Bernardo, B.C.; McMullen, J.R.; Ritchie, R.H. Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol. Ther. 2014, 142, 375–415. [Google Scholar] [CrossRef] [PubMed]
  19. Montezano, A.C.; Touyz, R.M. Review: Molecular mechanisms of hypertension—Reactive oxygen species and antioxidants: A basic science update for the clinician. Can. J. Cardiol. 2012, 28, 288–295. [Google Scholar] [CrossRef] [PubMed]
  20. Seifried, H.E.; Anderson, D.E.; Fisher, E.I.; Milner, J.A. A review of the interaction among dietary antioxidants and reactive oxygen species. J. Nutr. Biochem. 2007, 18, 567–579. [Google Scholar] [CrossRef] [PubMed]
  21. Wu, J.Q.; Kosten, T.R.; Zhang, X.Y. Free radicals, antioxidant defense systems, and schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 46, 200–206. [Google Scholar] [CrossRef] [PubMed]
  22. Halliwell, B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007, 35, 1147–1150. [Google Scholar] [CrossRef] [PubMed]
  23. Becker, L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 2004, 61, 461–470. [Google Scholar] [CrossRef] [PubMed]
  24. Martin, K.R.; Barrett, J.C. Reactive oxygen species as double-edgeds words in cellular processes: Low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol. 2002, 21, 71–75. [Google Scholar] [CrossRef] [PubMed]
  25. Nakashima, I.; Liu, W.; Akhand, A.A.; Takeda, K.; Kawamoto, Y.; Kato, M.; Suzuki, H. 4Hydroxynonenal triggers multi step signal transduction cascades for suppresion of cellular functions. Mol. Asp. Med. 2003, 24, 231–238. [Google Scholar] [CrossRef]
  26. Kardeh, S.; Ashkani-Esfahani, S.; Alizadeh, A.M. Review Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur. J. Pharmacol. 2014, 735, 150–168. [Google Scholar] [CrossRef] [PubMed]
  27. Kowaltowski, A.J.; Souza-Pinto, N.C.; Castilho, R.F.; Vercesi, A.E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 2009, 47, 333–343. [Google Scholar] [CrossRef] [PubMed]
  28. Witaicenis, A.; Seito, L.N.; Chagas, A.S.; Junior, L.D.A.; Luchini, A.C.; Rodrigues-Orsi, P.; Cestari, S.H.; Stasi, L.C. Antioxidantand intestinal anti-inflammatory effects of plant-derived coumarin derivatives. Phytomedicine 2014, 21, 240–246. [Google Scholar] [CrossRef] [PubMed]
  29. Thannickal, V.J. The paradox of reactive oxygen species: Injury, signaling, or both? Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284, L24–L25. [Google Scholar] [CrossRef] [PubMed]
  30. Gongora, M.C.; Qin, Z.; Laude, K.; Laude, K.; Kim, H.W.; Folz, J.R.; Dikalov, S.; Fukai, T.; Harrison, D.G. Role of extracellular superoxide dismutase in hypertension. Hypertension 2006, 48, 473–481. [Google Scholar] [CrossRef] [PubMed]
  31. Brusotti, G.; Ngueyem, T.A.; Biesuz, R.; Caccialanza, G. Optimum extraction process of polyphenols from Bridelia grandis stem bark using experimental design. J. Sep. Sci. 2010, 33, 1692–1697. [Google Scholar] [CrossRef] [PubMed]
  32. Halliwell, B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys. 2008, 476, 107–112. [Google Scholar] [CrossRef] [PubMed]
  33. Nour, V.; Stampar, F.; Veberic, R.; Jakopic, J. Anthocyanins profile, total phenolics and antioxidant activity of black currant ethanolic extracts as influenced by genotype and ethanol concentration. Food Chem. 2013, 141, 961–966. [Google Scholar] [CrossRef] [PubMed]
  34. Mandave, P.C.; Pawar, P.K.; Ranjekar, P.K.; Mantri, N.; Kuvalekar, A.A. Comprehensive evaluation of in vitro antioxidant activity, total phenols and chemical profiles of two commercially important strawberry varieties. Sci. Hortic. 2014, 172, 124–134. [Google Scholar] [CrossRef]
  35. Pace, B.; Renna, M.F.; Renna, M.; Serio, F.; Attolico, G. Multiple regression models and computer vision systems to predict antioxidant activity and total phenols in pigmented carrots. J. Food Eng. 2013, 117, 74–81. [Google Scholar] [CrossRef]
  36. Andrade, C.A.; Costa, C.K.; Bora, K.; Miguel, M.D.; Miguel, O.G.; Kerber, V.A. Determination of the phenolic content and evaluation of the antioxidant activity of Acacia podallyriifolia A. Cunn. ex. G. Don., Leguminosae-mimosoideae. Rev. Bras. Farmacogn. 2007, 17, 231–235. [Google Scholar] [CrossRef]
  37. Souza, C.M.M.; Silva, H.R.; Vieira, G.M., Jr.; Ayres, M.C.C.; Costa, C.L.S.; Araújo, D.S.; Cavalcante, L.C.D.; Barros, E.D.S.; Araújo, P.B.M. Total phenolics and antioxidant activity of five medicinal plants. Quim. Nova 2007, 30, 351–355. [Google Scholar]
  38. Maisuthisakul, P.; Suttajit, M.; Pongsawatmanit, R. Assessment of phenolic content and free radical-scavenging capacity of some Thai indigenous plants. Food Chem. 2007, 100, 1409–1418. [Google Scholar] [CrossRef]
  39. Serafini, M.R.; Santos, R.C.; Guimarães, A.G.; Santos, J.P.A.; Santos, A.D.C.; Alves, I.A.; Gelain, D.P.; Nogueira, P.C.L.; Quintans-Júnior, L.J.; Bonjardim, L.R.; et al. Morinda citrifolia Linn Leaf Extract Possesses Antioxidant Activities and Reduces Nociceptive Behavior and Leukocyte Migration. J. Med. Food 2011, 14, 1159–1166. [Google Scholar] [CrossRef] [PubMed]
  40. Beevi, S.S.; Narasu, M.L.; Gowda, B.B. Polyphenolics profile, antioxidant and radical scavenging activity of leaves and stem of Raphanus sativus L. Plant Foods Hum. Nutr. 2010, 65, 8–17. [Google Scholar] [CrossRef] [PubMed]
  41. Bhandari, S.R.; Kwak, J. Chemical composition and antioxidant activity in different tissues of Brassica vegetables. Molecules 2015, 20, 1228–1243. [Google Scholar] [CrossRef] [PubMed]
  42. Silva, E.G.; Behr, G.A.; Zanotto-Filho, A.; Lorenzi, R.; Pasquali, M.A.; Ravazolo, L.G.; Bordignon, C.L., Jr.; Silva, F.A.; Aboy, A.L.; Bassani, V.L.; et al. Antioxidant activities and free radical scavenging potential of Bauhinia microstachya (RADDI) MACBR (Caesalpinaceae) extracts linked to their polyphenol content. Biol. Pharm. Bull. 2007, 30, 1488–1496. [Google Scholar] [CrossRef] [PubMed]
  43. Lima, E.S.; Abdalla, D.A.P. Lipid peroxidatiom: Mechanisms and evaluation in biological samples. Braz. J. Pharm. Sci. 2001, 37, 293–303. [Google Scholar]
  44. Davies, S.S.; Guo, L. Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids. Review. Chem. Phys. Lipids 2014, 181, 1–33. [Google Scholar] [CrossRef] [PubMed]
  45. Li, X.; Lin, J.; Han, W.; Mai, W.; Wang, L.; Li, Q.; Lin, M.; Bai, M.; Zhang, L.; Chen, D. Antioxidant Ability and Mechanism of Rhizoma Atractylodes macrocephala. Molecules 2012, 17, 13457–13472. [Google Scholar] [CrossRef] [PubMed]
  46. Sun, L.; Gao, W.; Zhang, M.; Li, C.; Wang, A.; Su, Y.; Ji, T. Composition and Antioxidant Activity of the Anthocyanins of the Fruit of Berberis heteropoda Schrenk. Molecules 2014, 19, 19078–19096. [Google Scholar] [CrossRef] [PubMed]
  47. Fu, W.; Chen, J.; Cai, Y.; Lei, Y.; Chen, L.; Pei, L.; Zhou, D.; Liang, X.; Ruan, J. Antioxidant, free radical scavenging, anti-inflammatory and hepatoprotective potential of the extract from Parathelypteris nipponica (Franch. et Sav.) Ching. J. Ethnopharmacol. 2010, 130, 521–528. [Google Scholar] [CrossRef] [PubMed]
  48. Ibrahim, M.M.; Sahli, A.A.A.A.; Alaraidh, I.A.; Al-Homaidan, A.A.; Mostafa, E.M.; EL-Gaaly, G.A. Assessment of antioxidant activities in roots of Miswak (Salvadora persica) plants grown at two different locations in Saudi Arabia. Saudi J. Biol. Sci. 2015, 22, 168–175. [Google Scholar] [CrossRef] [PubMed]
  49. Conde-Hernández, L.A.; Guerrero-Beltrán, J.A. Total phenolics and antioxidant activity of Piper auritum and Porophyllum ruderale. Food Chem. 2014, 142, 455–460. [Google Scholar] [CrossRef] [PubMed]
  50. WHO (World Health Organization). Cancer 2012. Available online: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed on 1 November 2014).
  51. Badisa, R.B.; Mina, D.A.; Latinwo, L.M.; Solima, K.F.A. Selective Anticancer Activity of Neurotoxin 1-Methyl-4-Phenylpyridinium on Non-Small Cell Lung Adenocarcinoma A549 Cells. Anticancer Res. 2014, 34, 5447–5452. [Google Scholar] [PubMed]
  52. Caruso, Í.P.; Vilegas, W.; Souza, F.P.; Fossey, M.A.; Cornélio, M.L. Binding of antioxidant flavone isovitexin to human serum albumin investigated by experimental and computational assays. J. Pharm. Biomed. 2014, 98, 100–106. [Google Scholar] [CrossRef] [PubMed]
  53. Huang, S.T.; Chen, C.T.; Chieng, K.T.; Huang, S.H.; Chiang, B.H.; Wang, L.F.; Kuo, H.S.; Lin, C.M. Inhibitory effects of a rice hull constituent on tumor necrosis factor alpha, prostaglandin E2, and cyclooxygenase-2 production in lipopolysaccharide-activated mouse macrophages. Ann. N. Y. Acad Sci. 2005, 1042, 387–395. [Google Scholar] [CrossRef] [PubMed]
  54. Zhang, T.; Wu, W.; Li, D.; Xu, T.; Zhu, H.; Pan, D.; Zhu, S.; Liu, Y. Anti-oxidant and antiapoptotic effects of luteolin on mice peritoneal macrophages stimulated by angiotensin II. Int. J. Immunopharmacol. 2014, 20, 346–351. [Google Scholar] [CrossRef] [PubMed]
  55. Chiu, F.L.; Lin, J.K. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate 2008, 68, 61–71. [Google Scholar] [CrossRef] [PubMed]
  56. Lopez-Lazaro, M. Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 2009, 9, 31–59. [Google Scholar] [CrossRef] [PubMed]
  57. Seelinger, G.; Merfort, I.; Schempp, C.M. Anti-oxidant, anti-inflammatoryand anti-allergic activities of luteolin. Planta Med. 2008, 74, 1667–1677. [Google Scholar] [CrossRef] [PubMed]
  58. Horváthová, K.; Chalupa, I.; Sebová, L.; Tóthová, D.; Vachálková, A. Protective effect of quercetin and luteolin in human melanoma HMB-2 cells. Mutat. Res. 2005, 565, 105–112. [Google Scholar] [CrossRef] [PubMed]
  59. Park, Y.K.; Hikegaki, M.; Abreu, J.A.S.; Alcici, N.M.F. Estudo da preparação dos extratos de própolis e suas aplicações. Food Sci. Technol. 1998, 18, 313–318. [Google Scholar] [CrossRef]
  60. Attoub, S.; Hassan, A.H.; Vanhoecke, B.; Iratni, R.; Takahashi, T.; Gaben, A.M.; Bracke, M.; Awad, S.; John, A.; Kamalboor, H.A.; et al. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur. J. Pharmacol. 2011, 651, 18–25. [Google Scholar] [CrossRef] [PubMed]
  61. Can, O.D.; Ozkay, U.D.; Ucel, U.I. Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms. Eur. J. Pharmacol. 2013, 699, 250–257. [Google Scholar] [CrossRef] [PubMed]
  62. Cao, D.; Li, H.; Yi, J.; Zhang, J.; Che, H.; Cao, J.; Yang, L.; Zhu, C.; Jiang, W. Antioxidant properties of the mung bean flavonoids on alleviating heat stress. PLoS ONE 2011, 6, e21071. [Google Scholar] [CrossRef] [PubMed]
  63. Gorzalczany, S.; Marrassini, C.; Mino, J.; Acevedo, C.; Ferraro, G. Antinociceptive activity of ethanolic extract and isolated compounds of Urtica circularis. J. Ethnopharmacol. 2011, 134, 733–738. [Google Scholar] [CrossRef] [PubMed]
  64. Özkay, Ü.D.; Can, Ö.D. Anti-nociceptive effect of vitexin mediated by the opioid system in mice. Pharmacol. Biochem. Behav. 2013, 109, 23–30. [Google Scholar] [CrossRef] [PubMed]
  65. Knipping, K.; Garssen, J.; van’t Land, B. An evaluation of the inhibitory effects against rota-virus infection of edible plant extracts. Virol. J. 2012, 9, 137. [Google Scholar] [CrossRef] [PubMed]
  66. Abbasi, E.; Nassiri-Asl, M.; Shafeei, M.; Sheikhi, M. Neuroprotective effects of vitexin, a flavonoid, on pentylenetetrazole-induced seizure in rats. Chem. Biol. Drug Des. 2012, 80, 274–278. [Google Scholar] [CrossRef] [PubMed]
  67. Tan, Z.; Zhang, Y.; Deng, J.; Zeng, G.; Zhang, Y. Purified vitexin compound 1 suppresses tumor growth and induces cell apoptosis in a mouse model of human choriocarcinoma. Int. J. Gynecol. Cancer 2012, 22, 360–366. [Google Scholar] [CrossRef] [PubMed]
  68. Zhou, Y.J.; Liu, Y.E.; Cao, J.G.; Zeng, G.Y.; Shen, C.; Li, Y.L.; Zhou, M.C.; Chen, Y.; Pu, W.; Potters, L.; et al. Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin. Cancer Res. 2009, 15, 5161–5169. [Google Scholar] [CrossRef] [PubMed]
  69. Singleton, V.L.; Orthofer, R.; Lamuela-Raventos, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999, 299, 152–178. [Google Scholar]
  70. López-Alarcón, C.; Denicola, A. Evaluating the antioxidant capacity of natural products: A review on chemical and cellular-based assays. Anal. Chim. Acta 2013, 763, 1–10. [Google Scholar] [CrossRef] [PubMed]
  71. Alam, M.N.; Bristi, N.J.; Rafiquzzaman, M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm. J. 2013, 21, 143–152. [Google Scholar] [CrossRef] [PubMed]
  72. Bittencourt, L.S.; Zeidán-Chuliá, F.; Yatsu, F.K.J.; Schnorr, C.E.; Moresco, K.S.; Kolling, E.A.; Gelain, D.P.; Bassani, V.L.; Moreira, J.C.F. Guarana (Paullinia cupana Mart.) prevents β-amyloid aggregation, generation of advanced glycation-end products (AGEs), and acrolein-induced cytotoxicity on human neuronal-like cells. Phytother. Res. 2014, 28, 1615–1624. [Google Scholar] [CrossRef] [PubMed]
  73. Dresch, M.T.; Rossato, S.B.; Kappel, V.D.; Biegelmeyer, R.; Hoff, M.L.; Mayorga, P.; Zuanazzi, J.A.; Henriques, A.T.; Moreira, J.C. Optimization and validation of an alternative method to evaluate total reactive antioxidant potential. Anal. Biochem. 2009, 385, 107–114. [Google Scholar] [CrossRef] [PubMed]
  74. Lissi, E.A.; Salim-Hanna, M.; Pascual, C.; Del Castillo, M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity (TAR) from luminol enhanced chemiluminescence measurements. Free Radic. Biol. Med. 1995, 18, 153–158. [Google Scholar] [CrossRef]
  75. Lopes, G.K.; Schulman, H.M.; Hermes-Lima, M. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. Biochim. Biophys. Acta 1999, 1472, 142–152. [Google Scholar] [CrossRef]
  76. Cheng, N.; Wang, Y.; Gao, H.; Yuan, J.; Feng, F.; Cao, W.; Zheng, J. Protective effect of extract of Crataegus pinnatifida pollen on DNA damage response to oxidative stress. Food Chem. Toxicol. 2013, 59, 709–714. [Google Scholar] [CrossRef] [PubMed]
  77. Basu, S.; Hazra, B. Evaluation of nitric oxide scavenging activity, in vitro and ex vivo, of selected medicinal plants traditionally used in inflammatory diseases. Phytother. Res. 2006, 20, 896–900. [Google Scholar] [CrossRef] [PubMed]
  78. Draper, H.H.; Hadley, M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990, 186, 421–431. [Google Scholar] [PubMed]
  79. Melo, M.G.D.; Santos, J.P.A.; Serafini, M.R.; Caregnato, F.F.; Pasquali, M.A.B.; Rabelo, T.K.; Rocha, R.F.; Quintans, L.J., Jr.; Araújo, A.A.S.; Silva, F.A.; et al. Redox properties and cytoprotective actions of atranorin, a lichen secondary metabolite. Toxicol. in Vitro 2011, 25, 462–468. [Google Scholar] [CrossRef] [PubMed]
  80. Borenfreund, E.; Babich, H.; Martin-Alguacil, N. Comparisons of two in vitro cytotoxicity assays-the neutral red (NR) and tetrazoliummtt tests. Toxicol. in Vitro 1988, 2, 1–6. [Google Scholar] [CrossRef]
  81. Cao, T.; Saw, T.Y.; Heng, B.C.; Liu, H.; Yap, A.U.J.; Ng, M.L. Comparison of different test models for the assessment of cytotoxicity of composite resins. J. Appl. Toxicol. 2005, 25, 101–108. [Google Scholar] [CrossRef] [PubMed]
  • Sample Availability: Samples of the Remirea maritima extract are available from the authors.

Share and Cite

MDPI and ACS Style

Dória, G.A.A.; Santos, A.R.; Bittencourt, L.S.; Bortolin, R.C.; Menezes, P.P.; Vasconcelos, B.S.; Souza, R.O.; Fonseca, M.J.V.; Santos, A.D.C.; Saravanan, S.; et al. Redox-Active Profile Characterization of Remirea maritima Extracts and Its Cytotoxic Effect in Mouse Fibroblasts (L929) and Melanoma (B16F10) Cells. Molecules 2015, 20, 11699-11718. https://doi.org/10.3390/molecules200711699

AMA Style

Dória GAA, Santos AR, Bittencourt LS, Bortolin RC, Menezes PP, Vasconcelos BS, Souza RO, Fonseca MJV, Santos ADC, Saravanan S, et al. Redox-Active Profile Characterization of Remirea maritima Extracts and Its Cytotoxic Effect in Mouse Fibroblasts (L929) and Melanoma (B16F10) Cells. Molecules. 2015; 20(7):11699-11718. https://doi.org/10.3390/molecules200711699

Chicago/Turabian Style

Dória, Grace Anne A., Anderson R. Santos, Leonardo S. Bittencourt, Rafael C. Bortolin, Paula P. Menezes, Bruno S. Vasconcelos, Rebeca O. Souza, Maria José V. Fonseca, Alan Diego C. Santos, Shanmugam Saravanan, and et al. 2015. "Redox-Active Profile Characterization of Remirea maritima Extracts and Its Cytotoxic Effect in Mouse Fibroblasts (L929) and Melanoma (B16F10) Cells" Molecules 20, no. 7: 11699-11718. https://doi.org/10.3390/molecules200711699

APA Style

Dória, G. A. A., Santos, A. R., Bittencourt, L. S., Bortolin, R. C., Menezes, P. P., Vasconcelos, B. S., Souza, R. O., Fonseca, M. J. V., Santos, A. D. C., Saravanan, S., Silva, F. A., Gelain, D. P., Moreira, J. C. F., Prata, A. P. N., Quintans-Júnior, L. J., & Araújo, A. A. S. (2015). Redox-Active Profile Characterization of Remirea maritima Extracts and Its Cytotoxic Effect in Mouse Fibroblasts (L929) and Melanoma (B16F10) Cells. Molecules, 20(7), 11699-11718. https://doi.org/10.3390/molecules200711699

Article Metrics

Back to TopTop